News segment highlights perks of shopping at drug stores
NEW YORK — Local retail pharmacies are not just a place to get a prescription filled; they also offer several perks that can help consumers save time and money and live healthier lives. That was a key message in a recent "CBS News" segment.
The "Drugstore bonuses" segment on April 19 showcased an article in the May issue of ShopSmart magazine that focused on how pharmacy services make drug stores and pharmacists an ideal resource for patients.
Services discussed during the segment included private pharmacist-patient consultations, health screenings, home delivery of prescription medications and discounted generic drug programs. Some pharmacies also are offering credit accounts for customers and such custom services as on-staff "shoppers" who can help customers find an ideal gift.
The CBS segment highlighted the fact that many patients are unaware that some of these services are available at their local pharmacy and that taking advantage of them can save time, money and, in some cases, even a trip to the physician.
GSK applauds agreement to support global preparedness against pandemic influenza
LONDON — Companies that make vaccines, drugs and diagnostic tests for influenza will become key stakeholders in the World Health Organization’s Global Influenza Surveillance Network under an agreement reached at the Open Ended Working Group that WHO coordinated to support global preparedness for a future influenza pandemic.
British drug maker GlaxoSmithKline heralded the agreement, under which companies will increase their financial contributions to the GISN to enable the network’s geographical expansion and support technical improvements to accelerate the start of vaccine production, thus allowing them to deliver vaccines more quickly.
“This framework agreement is a critical step in ensuring that the world, including developing countries, is able to prepare properly and equitably for any future pandemic,” GSK CEO Andrew Witty said. “I applaud the leadership of WHO. Member states and the industry have demonstrated a shared commitment to addressing global needs and an ability to work together and compromise.”
Merck, Sanofi commence late-stage trial for childhood diseases vaccine
WHITEHOUSE STATION, N.J. — Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.
The companies announced a phase-3 trial of the vaccine for diphtheria, tetanus, whooping cough, polio, hepatitis B and invasive disease caused by Haemophilus influenzae type b. The trial will involve about 1,440 infants at multiple centers, with the primary goal of assessing safety and immunogenicity compared with Pfizer’s pneumococcal disease vaccine Prevnar 13 and Merck’s rotavirus vaccine RotaTeq.
“Combination vaccines simplify the childhood immunization schedule and may improve coverage [and] on-time vaccination, and [may] reduce the number of injections for children,” University of Louisville School of Medicine professor of pediatrics Gary Marshall said on behalf of the companies.